{"id":"W2596356909","doi":"10.1200/jco.2014.32.15_suppl.8013","title":"Pan-Canadian rash trial with EGFR inhibitors.","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Abbott (Canada); Princess Margaret Cancer Centre; Baker Hughes (Canada); Mount Sinai Hospital; BC Cancer Agency","funders":"","keywords":"Erlotinib; Rash; Medicine; Erlotinib Hydrochloride; Internal medicine; Minocycline; Dermatology; Surgery; Cancer; Epidermal growth factor receptor; Antibiotics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007010063,0.0006147923,0.0007335079,0.0001793598,0.0005705463,0.0004795563,0.0004915881,0.0006768084,0.01209862],"category_scores_gemma":[0.0006723214,0.0001624866,0.000856615,0.000391036,0.0003246964,0.000316958,0.0002595591,0.001354658,0.0007232392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00489728,"about_ca_system_score_gemma":0.007115622,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1576719,"about_ca_topic_score_gemma":0.5435163,"domain_scores_codex":[0.9996948,0.00009414154,0.00001111103,0.00004405707,0.00006611612,0.00008975256],"domain_scores_gemma":[0.9996896,0.00002720182,0.00005670654,0.00001117561,0.00005089453,0.000164501],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7744622,0.004374763,0.007685147,0.002370224,0.00192953,0.0001883064,0.0000894558,0.001111141,0.00581485,0.001473195,0.04583107,0.1546701],"study_design_scores_gemma":[0.7298898,0.07643107,0.09933334,0.0004474748,0.002460054,0.0006168104,0.0001815555,0.001649242,0.001715054,0.000937605,0.08625112,0.00008701395],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8767202,0.03883721,0.0005362143,0.005675917,0.000934183,0.003683581,0.01783535,0.0002136812,0.05556373],"genre_scores_gemma":[0.9466684,0.008953029,0.001288462,0.004374519,0.0003153335,0.001544636,0.008050383,0.00002702699,0.02877824],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8423281,"threshold_uncertainty_score":0.3135082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07618340137758299,"score_gpt":0.4909951274497495,"score_spread":0.4148117260721665,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}